HansBiomed Corporation (KOSDAQ:042520)
South Korea
· Delayed Price · Currency is KRW 7,150.00
-10.00 (-0.14%)
Last updated: May 12, 2025
HansBiomed Cash Flow Statement
Financials in millions KRW. Fiscal year is October - September.
Millions KRW. Fiscal year is Oct - Sep.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2015 - 2019 |
| Net Income | -7,223 | -23,045 | 6,147 | -18,289 | -17,840 | Upgrade
|
| Depreciation & Amortization | 5,386 | 5,198 | 4,902 | 4,785 | 3,613 | Upgrade
|
| Loss (Gain) From Sale of Assets | 73.02 | 16.98 | -1.6 | -54.82 | 2.39 | Upgrade
|
| Asset Writedown & Restructuring Costs | -4.4 | 366.16 | - | - | 9,118 | Upgrade
|
| Loss (Gain) From Sale of Investments | 1,658 | - | - | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | 2,235 | 1,857 | 2,644 | - | - | Upgrade
|
| Stock-Based Compensation | 42.57 | 2,447 | 59.76 | 226.06 | 225.4 | Upgrade
|
| Provision & Write-off of Bad Debts | 1,568 | -116.39 | 153.96 | 2,780 | 12.12 | Upgrade
|
| Other Operating Activities | 2,145 | 14,779 | -11,797 | -5,228 | 15,539 | Upgrade
|
| Change in Accounts Receivable | -2,215 | -3,621 | -748.02 | 694.62 | -2,834 | Upgrade
|
| Change in Inventory | -2,558 | -2,645 | -5,963 | 3,482 | -6,968 | Upgrade
|
| Change in Accounts Payable | 814.94 | 1,062 | -1,638 | -1,554 | 926.99 | Upgrade
|
| Change in Income Taxes | - | -124.27 | - | - | -7.31 | Upgrade
|
| Change in Other Net Operating Assets | -163.16 | 91.85 | 1,971 | -1,487 | 3,962 | Upgrade
|
| Operating Cash Flow | 1,759 | -3,733 | -4,270 | -14,645 | 5,751 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | -25.45% | Upgrade
|
| Capital Expenditures | -2,594 | -1,937 | -3,986 | -4,891 | -7,046 | Upgrade
|
| Sale of Property, Plant & Equipment | 61.27 | 72.39 | 80.81 | 48.7 | 15.45 | Upgrade
|
| Sale (Purchase) of Intangibles | -234.71 | -135.76 | -147.84 | -87.04 | -926.89 | Upgrade
|
| Investment in Securities | -3,791 | 5,113 | 7,188 | -16,323 | 6,529 | Upgrade
|
| Other Investing Activities | -22.8 | 10.65 | -28.86 | 19.78 | -42.53 | Upgrade
|
| Investing Cash Flow | -6,595 | 3,320 | 3,167 | -21,190 | -1,329 | Upgrade
|
| Long-Term Debt Issued | 7,000 | - | 15,000 | 37,976 | 2,546 | Upgrade
|
| Total Debt Issued | 7,000 | - | 15,000 | 37,976 | 2,546 | Upgrade
|
| Long-Term Debt Repaid | -1,130 | -1,093 | -9,925 | -16,919 | -2,823 | Upgrade
|
| Net Debt Issued (Repaid) | 5,870 | -1,093 | 5,075 | 21,057 | -277.44 | Upgrade
|
| Issuance of Common Stock | - | - | - | 7,497 | - | Upgrade
|
| Repurchase of Common Stock | -5 | -788.29 | -4,553 | -20 | -847.54 | Upgrade
|
| Common Dividends Paid | - | - | - | - | -1,184 | Upgrade
|
| Other Financing Activities | -0 | 1,053 | 864.28 | 1,204 | 1,186 | Upgrade
|
| Financing Cash Flow | 5,865 | -828.51 | 1,387 | 29,738 | -1,122 | Upgrade
|
| Foreign Exchange Rate Adjustments | 99 | -151.03 | 189.65 | 134.72 | -62.1 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | -827.63 | 198.99 | Upgrade
|
| Net Cash Flow | 1,128 | -1,392 | 473.14 | -6,790 | 3,436 | Upgrade
|
| Free Cash Flow | -835.74 | -5,670 | -8,256 | -19,535 | -1,295 | Upgrade
|
| Free Cash Flow Margin | -1.03% | -7.27% | -11.09% | -33.06% | -1.62% | Upgrade
|
| Free Cash Flow Per Share | -64.54 | -529.02 | -628.48 | -1951.22 | -131.27 | Upgrade
|
| Cash Interest Paid | 1,632 | 1,381 | 794.56 | 611.45 | 325.92 | Upgrade
|
| Cash Income Tax Paid | 327.7 | 214.65 | 243.11 | 1,505 | 2,645 | Upgrade
|
| Levered Free Cash Flow | -7,421 | 1,977 | -16,356 | -3,746 | -6,587 | Upgrade
|
| Unlevered Free Cash Flow | -6,311 | 5,429 | -12,429 | -1,560 | -5,733 | Upgrade
|
| Change in Net Working Capital | 9,301 | -2,453 | 14,042 | -10,995 | -756.23 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.